Halozyme Therapeutics, Inc. News - HALO

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$31.00
CHART Trader
Monthly Subscription
for only
$27.87
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$60.99
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Halozyme Therapeutics, Inc. HALO NASDAQ Common Stock US40637H1095
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.04 +0.21% 19.28 20.03 19.25 19.52 19.24 20:00:00
more quote information »
Industry Sector
Biotechnology

Recent News

Date Time Source Heading
2/20/201816:20EDGARAnnual Report (10-k)
2/20/201816:12EDGARCurrent Report Filing (8-k)
2/20/201816:05PRNUSHalozyme Reports Fourth Quarter And Full-Year 2017 Results
2/16/201816:10EDGARStatement of Changes in Beneficial Ownership (4)
2/16/201816:09EDGARStatement of Changes in Beneficial Ownership (4)
2/16/201816:09EDGARStatement of Changes in Beneficial Ownership (4)
2/14/201815:48EDGARAmended Statement of Ownership (sc 13g/a)
2/13/201809:54EDGARAmended Statement of Ownership (sc 13g/a)
2/09/201812:01EDGARAmended Statement of Ownership (sc 13g/a)
2/06/201809:15EDGARAmended Statement of Ownership (sc 13g/a)
2/05/201816:29EDGARStatement of Changes in Beneficial Ownership (4)
2/05/201816:26EDGARStatement of Changes in Beneficial Ownership (4)
2/05/201816:24EDGARStatement of Changes in Beneficial Ownership (4)
2/05/201813:33EDGARAmended Statement of Ownership (sc 13g/a)
1/25/201811:22EDGARAmended Statement of Ownership (sc 13g/a)
1/22/201808:00PRNUSHalozyme To Host Fourth Quarter And Full-Year 2017 Financial..
1/12/201816:06EDGARCurrent Report Filing (8-k)
1/10/201806:05EDGARCurrent Report Filing (8-k)
1/09/201818:36EDGARStatement of Changes in Beneficial Ownership (4)
1/09/201818:30PRNUSHalozyme Projects 25 To 30 Percent ENHANZE Royalty Growth In..
12/27/201708:00PRNUSHalozyme Therapeutics To Present At The 36th Annual J.P...
12/07/201706:30BWAlexion and Halozyme Enter License Agreement for ENHANZE..
11/15/201708:00PRNUSHalozyme Therapeutics To Participate In Upcoming Healthcare..
11/10/201708:30PRNUSHalozyme To Present Nonclinical Data At SITC 2017 Supporting..
11/07/201716:17EDGARQuarterly Report (10-q)
11/07/201716:13EDGARCurrent Report Filing (8-k)
11/07/201716:05PRNUSHalozyme Reports Third Quarter 2017 Results
10/31/201708:30PRNUSPhase 3 Study Of Subcutanous Daratumumab Initiated Using..
10/24/201708:30PRNUSFirst Gastric Cancer Patient Dosed In Clinical Trial..
10/16/201708:00PRNUSHalozyme Initiates Clinical Trial Of PEGPH20 With Anti-PDL1..
10/10/201708:00PRNUSHalozyme to Host Third Quarter 2017 Financial Results..
9/29/201716:33EDGARCurrent Report Filing (8-k)
9/21/201719:21EDGARStatement of Changes in Beneficial Ownership (4)
9/15/201709:00PRNUSFinancialInsiders.com Earnings Recap Week Ending September..
9/14/201707:05PRNUSHalozyme Licenses New Enhanze Target For $30 Million Upfront..
9/14/201707:05PRNUSHalozyme Increases 2017 Financial Guidance
9/14/201706:59BWBristol-Myers Squibb and Halozyme Enter Global Collaboration..
8/25/201708:00PRNUSHalozyme Therapeutics To Present At Upcoming Healthcare..
8/08/201716:16EDGARQuarterly Report (10-q)
8/08/201716:11EDGARCurrent Report Filing (8-k)
8/08/201716:05PRNUSHalozyme Reports Second Quarter 2017 Results
8/04/201716:15PRNUSHalozyme Therapeutics To Present At Upcoming Healthcare..
7/26/201717:29EDGARStatement of Changes in Beneficial Ownership (4)
7/26/201717:25EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
7/13/201708:30PRNUSInitiation Of Clinical Trial Collaboration Evaluating..
7/10/201716:15PRNUSHalozyme To Host Second Quarter 2017 Financial Results..
7/05/201716:07EDGARCurrent Report Filing (8-k)
6/28/201712:00PRNUSHalozyme Phase 2 Data In Advanced Pancreas Cancer Presented..
6/22/201715:16PRNUSFDA Approves Genentech's RITUXAN HYCELA, A Subcutaneous..
6/16/201716:12EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.